Incyte incyte.com


Public lists: Pharma Startups (6570)

Incyte seeks to build a product pipeline of small molecule drugs.

Incyte seeks to build a product pipeline of small molecule drugs.

Company (IPO / Went public)

Phone: 855-463-3463

Fax:

1801 Augustine Cut-off

Wilmington, 19803
Delaware, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Incyte $0M Nov 5, 1993
Five Prime Therapeutics $178.4M Apr 16, 2021
Active Pass Pharmaceuticals $0M May 9, 2021
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Incyte Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

Competitors

Company Status Description Investors
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Heterocyclic compounds as pi3k-y inhibitors Oct 02, 2019 Apr 13, 2021 Patent
Advanced gaming visualization system Jun 12, 2019 Apr 13, 2021 Patent
Processes for preparing jak inhibitors and related intermediate compounds Jun 10, 2019 Apr 13, 2021 Patent
Triazolopyridines and triazolopyrazines as lsd1 inhibitors Oct 03, 2019 Apr 06, 2021 Patent
Salts of an lsd1 inhibitor and processes for preparing the same Aug 29, 2019 Apr 06, 2021 Patent
See all 503 patents